Paper21079040
Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.
Löscher W and 1 other. Pharmacol Rev, 2010. Cited by 322 papers, by iCite.
Cite this record
ConductScience Library. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Papers, record 21079040. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21079040
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticonvulsants | Major topic |
| Epilepsy | Major topic |
| Animals | |
| Brain Injuries | |
| Disease Models, Animal | |
| Humans | |
| Stroke | |
| Translational Research, Biomedical |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R21 NS049592 | NINDS NIH HHS | United States | R21NS049592 | PubMed and NIH |
| R21-NS049592 | NINDS NIH HHS | United States | R21NS049592 | PubMed and NIH |
Source NIH RePORTER
References245
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12428028 | Epilepsy after brain insult: targeting epileptogenesis. | Neurology | 2002 | https://conductscience.org/library/papers/12428028 | PubMed |
| 2 | 17029741 | Effect of levetiracetam on visual-spatial memory following status epilepticus. | Epilepsy Res | 2007 | https://conductscience.org/library/papers/17029741 | PubMed |
| 3 | 18070091 | Early treatment suppresses the development of spike-wave epilepsy in a rat model. | Epilepsia | 2008 | https://conductscience.org/library/papers/18070091 | PubMed |
| 4 | 12399072 | Effect of topiramate following recurrent and prolonged seizures during early development. | Epilepsy Res | 2002 | https://conductscience.org/library/papers/12399072 | PubMed |
| 5 | 14584819 | The recurrent mossy fiber pathway of the epileptic brain. | Neurochem Res | 2003 | https://conductscience.org/library/papers/14584819 | PubMed |
| 6 | 20573906 | Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy. | J Neurosci | 2010 | https://conductscience.org/library/papers/20573906 | PubMed |
| 7 | 18389497 | Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. | Ann Neurol | 2008 | https://conductscience.org/library/papers/18389497 | PubMed |
| 8 | 9108112 | Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9108112 | PubMed |
| 9 | 16709666 | Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16709666 | PubMed |
| 10 | 9865538 | Hippocampal sclerosis revisited. | Brain Dev | 1998 | https://conductscience.org/library/papers/9865538 | PubMed |
| 11 | 18590620 | New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels. | Curr Neurol Neurosci Rep | 2008 | https://conductscience.org/library/papers/18590620 | PubMed |
| 12 | 15571506 | Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus. | Epilepsia | 2004 | https://conductscience.org/library/papers/15571506 | PubMed |
| 13 | 18330004 | Neuroprotection in epilepsy. | Epilepsia | 2007 | https://conductscience.org/library/papers/18330004 | PubMed |
| 14 | 16439585 | Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects. | Pediatr Res | 2006 | https://conductscience.org/library/papers/16439585 | PubMed |
| 15 | 12183340 | Disease modification in partial epilepsy. | Brain | 2002 | https://conductscience.org/library/papers/12183340 | PubMed |
| 16 | 10768292 | An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. | Epilepsia | 2000 | https://conductscience.org/library/papers/10768292 | PubMed |
| 17 | 17571349 | Epileptogenesis in experimental models. | Epilepsia | 2007 | https://conductscience.org/library/papers/17571349 | PubMed |
| 18 | 17521347 | The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation. | Epilepsia | 2007 | https://conductscience.org/library/papers/17521347 | PubMed |
| 19 | 14568348 | Changes in chloride homeostasis-regulating gene expressions in the rat hippocampus following amygdala kindling. | Brain Res | 2003 | https://conductscience.org/library/papers/14568348 | PubMed |
| 20 | 2289478 | The effect of interstimulation interval on the assessment of anticonvulsant drug potency in fully kindled rats. | Epilepsy Res | 1990 | https://conductscience.org/library/papers/2289478 | PubMed |
Cited by167
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 322 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939870 | CDDO-EA Attenuates Acute Seizures and Suppresses Post-Status Epilepticus Epileptogenesis. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42939870 | PubMed |
| 42794755 | Advancing the Paradigm of Temporal Lobe Epilepsy as a Network Disease: The Promise of Biomarkers and Targeted Disease Modification. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794755 | PubMed |
| 42794466 | GLP-1 Receptor Agonists in Epilepsy: Separating Evidence for Antiseizure Activity, Neuroprotection, and Disease Modification. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794466 | PubMed |
| 42651840 | Selected Molecular Targets for Counteracting Epileptogenesis: What Do We Know About Its Effective Inhibition? | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42651840 | PubMed |
| 42357670 | Human Herpesvirus-6A and -6B (HHV-6A and HHV-6B): The Role of Roseoloviruses in Neurological Dysfunction and the Mechanisms of Viral-Induced Epileptogenesis. | Viruses | 2026 | https://conductscience.org/library/papers/42357670 | PubMed |
| 42017361 | A consensus roadmap for post-traumatic epilepsy: Clinical biomarkers, research priorities, policy barriers, and pathways to interventional trials. | Epilepsia | 2026 | https://conductscience.org/library/papers/42017361 | PubMed |
| 41997955 | Perirhinal cortex gains control of hippocampal seizures via broad downstream circuits in male mouse models. | Nat Commun | 2026 | https://conductscience.org/library/papers/41997955 | PubMed |
| 41915362 | The Complexity and Challenges of Developing Effective Epilepsy Therapies: Lessons to be Learned from Comparing Cenobamate, Carisbamate, and Padsevonil. | CNS Drugs | 2026 | https://conductscience.org/library/papers/41915362 | PubMed |
| 41591075 | The Role of Blood-Brain Barrier Disruption in Epilepsy: Mechanisms and Consequences. | Neurol Int | 2025 | https://conductscience.org/library/papers/41591075 | PubMed |
| 41320877 | Diverse species of animal models in epilepsy research: Progress and perspectives. | Zool Res | 2025 | https://conductscience.org/library/papers/41320877 | PubMed |
| 41096582 | Organophosphate Chemical Nerve Agents, Oxidative Stress, and NADPH Oxidase Inhibitors: An Overview. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096582 | PubMed |
| 41045366 | Brivaracetam and Topiramate Co-Therapy Attenuates Seizure Progression, Neuroinflammation, and Hippocampal Pathology in Chronic Pentylenetetrazole-Kindled Mice. | Neurochem Res | 2025 | https://conductscience.org/library/papers/41045366 | PubMed |
| 40839114 | Modulation of epileptogenesis through transplantation of human mesenchymal stem cells with or without GDNF release. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/40839114 | PubMed |
| 40430067 | Reversing Epigenetic Dysregulation in Neurodegenerative Diseases: Mechanistic and Therapeutic Considerations. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40430067 | PubMed |
| 40430045 | Distribution of NECAB1-Positive Neurons in Normal and Epileptic Brain-Expression Changes in Temporal Lobe Epilepsy and Modulation by Levetiracetam and Brivaracetam. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40430045 | PubMed |
| 40296431 | Calpastatin, a calpain specific inhibitor, reduce seizures in a mouse model of temporal lobe epilepsy. | Epilepsia Open | 2025 | https://conductscience.org/library/papers/40296431 | PubMed |
| 40285834 | Anticonvulsant effects of noscapine against status epilepticus induced by lithium-pilocarpine in rats: involvement of Nrf2/HO-1 and NLRP3 pathways. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40285834 | PubMed |
| 40262903 | High-Order Information Analysis of Epileptogenesis in the Pilocarpine Rat Model of Temporal Lobe Epilepsy. | eNeuro | 2025 | https://conductscience.org/library/papers/40262903 | PubMed |
| 40228896 | Mitochondrial Glutamine Metabolism Drives Epileptogenesis in Primary Hippocampal Neurons. | J Neurosci | 2025 | https://conductscience.org/library/papers/40228896 | PubMed |
| 40207615 | Voxel-Based Lesion Symptom Mapping to Predict Poststroke Epilepsy After Mechanical Thrombectomy. | Eur J Neurol | 2025 | https://conductscience.org/library/papers/40207615 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21079040
GET https://conductscience.org/api/papers/v1/21079040/references?page=2